EUVIMEDEUVIMED entdecken
Crossref

Laser interstitial thermal therapy in older patients with drug‐resistant mesial temporal lobe epilepsy

Joanne Lau iD, Erica Von Stein iD, David Hartmann iD, Scheherazade Le iD, Jessica Falco-Walter iD, Robert Fisher iD, Ashwin Ramayya iD, Vivek Buch iD, Niyatee Samudra iD

Epileptic Disorders · 16.11.2026

DOI: 10.1002/epd2.70468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epileptic Disorders, online erschienen am 16.11.2026. Verfasst von Joanne Lau und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Stanford Comprehensive Epilepsy Center, Stanford, California, USA. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Laser interstitial thermal therapy (LITT) is a minimally invasive treatment for focal drug‐resistant epilepsy (DRE). This study sought to examine the efficacy of LITT for a cohort of older adults with mesial temporal lobe epilepsy (MTLE) and evaluate predictors of safety.

Methods

We examined 24 patients aged ≥50 years, with 10/24 (42%) ≥60 years. Primary outcomes were Engel classification and reduction from baseline seizure frequency. We additionally reviewed post‐ablation complications, hospital length of stay (LOS), neurocognitive and psychiatric worsening, and anti‐seizure medication (ASM) reduction. The Charlson Comorbidity Index (CCI) was calculated to assess its utility in prediction of postoperative complications.

Results

22/24 (92%) had ≥50% reduction in seizure frequency, and 17/24 (71%) had ≥90% reduction at last follow‐up, with median follow‐up of 5.2 years (range, 1.5–10.4 years). Engel Class I outcome was achieved in 19/24 (79%) of patients by 6 months post‐ablation and maintained in 12/24 (50%) of patients by last follow‐up. Immediate postoperative complications were mostly transient, though worse cognitive symptoms were reported in 5/24 (21%), and worse mood was reported in 3/24 (13%) at 6 months post‐ablation. Higher CCI did not correlate with complications but was associated with prolonged LOS. ASM reduction occurred in half of patients. Significance In our cohort, LITT offered favorable seizure and safety outcomes in an older population with focal DRE. Perioperative risk assessments such as the CCI may be useful in older patient selection for LITT.

Schlagwörter

Stichwörter der Autor:innen

drug‐resistant epilepsyepilepsylaser therapymesial temporal lobeolder adults

Autor:innen und Institutionen

  • Department of Neurology, Stanford Comprehensive Epilepsy Center, Stanford, California, USA.
  • Department of Neurological Surgery, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Joanne Lau, Erica Von Stein, David Hartmann, Scheherazade Le, Jessica Falco-Walter, Robert Fisher, Ashwin Ramayya, Vivek Buch, Niyatee Samudra

Zitieren

APA

Lau, J., Von Stein, E., Hartmann, D., Le, S., Falco-Walter, J., Fisher, R., Ramayya, A., Buch, V., & Samudra, N. (2026). Laser interstitial thermal therapy in older patients with drug‐resistant mesial temporal lobe epilepsy. Epileptic Disorders. https://doi.org/10.1002/epd2.70468

Vancouver

Lau J, Von Stein E, Hartmann D, Le S, Falco-Walter J, Fisher R, et al. Laser interstitial thermal therapy in older patients with drug‐resistant mesial temporal lobe epilepsy. Epileptic Disorders. 2026. doi:10.1002/epd2.70468

BibTeX
@article{Lau2026,
  author = {Lau, Joanne and Von Stein, Erica and Hartmann, David and Le, Scheherazade and Falco-Walter, Jessica and Fisher, Robert and Ramayya, Ashwin and Buch, Vivek and Samudra, Niyatee},
  title = {Laser interstitial thermal therapy in older patients with drug‐resistant mesial temporal lobe epilepsy},
  journal = {Epileptic Disorders},
  year = {2026},
  doi = {10.1002/epd2.70468}
}
Kostenlos starten →